-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Acurx Pharmaceuticals, Inc. annual and quarterly Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
- Acurx Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was $2,051,499, a 33% increase year-over-year.
- Acurx Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2025 was $6,787,782, a 35% increase from 2024.
- Acurx Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $10,383,431, a 5.9% decline from 2023.
- Acurx Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $9,800,885, a 30% decline from 2022.